Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 21 full-time employees. The company has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. The company specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. The company eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Ingresos
0
0
0
0
0
0
Crecimiento de los Ingresos (YoY)
--
--
--
--
--
--
Costo de los ingresos
--
--
--
--
--
--
Utilidad bruta
--
--
--
--
--
--
Venta, General y Administración
8
8
5
4
5
5
Investigación y Desarrollo
6
6
6
5
7
5
Gastos de Operación
14
14
11
9
13
11
Otras Ingresos (Gastos) No Operativos
--
--
--
--
--
--
Ingreso antes de impuestos
-13
-13
-11
-10
-13
-11
Gasto por Impuesto a la Renta
--
--
--
--
--
--
Ingreso Neto
-13
-13
-11
-10
-13
-11
Crecimiento de la Utilidad Neta
18%
18%
10%
-23%
18%
22%
Acciones en Circulación (Diluidas)
67.3
45.79
15.64
10.2
7.26
7.11
Cambio de Acciones (YoY)
292%
193%
53%
41%
2%
0%
EPS (Diluido)
-0.19
-0.28
-0.73
-1.05
-1.81
-1.59
Crecimiento de EPS
-71%
-61%
-31%
-42%
14%
23%
Flujo de efectivo libre
-13
-13
-8
-8
-11
-9
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
--
--
--
--
--
--
Margen de operación
0%
0%
0%
0%
0%
0%
Margen de beneficio
0%
0%
0%
0%
0%
0%
Margen de flujo de caja libre
0%
0%
0%
0%
0%
0%
EBITDA
-14
-14
-11
-9
-13
-11
Margen de EBITDA
0%
0%
0%
0%
0%
0%
D&A para EBITDA
0
0
0
0
0
0
EBIT
-14
-14
-11
-9
-13
-11
Margen de EBIT
0%
0%
0%
0%
0%
0%
Tasa de Impuesto Efectiva
--
--
--
--
--
--
Follow-Up Questions
Microbot Medical Inc'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Microbot Medical Inc'in toplam varlıkları $81 olup, net pérdida $-13'dir.
MBOT'ün temel finansal oranları nelerdir?
Microbot Medical Inc'in cari oranı 27, net kâr marjı 0, hisse başına satış $0'dir.
Microbot Medical Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?
El segmento de ingresos más grande es Microbot Medical Inc, con unos ingresos de Rubber Reinforcement en el último informe de ganancias. En cuanto a la geografía, Other Countries es el mercado principal para Microbot Medical Inc, con unos ingresos de 1,461,726,000.
Microbot Medical Inc kârlı mı?
no, son mali tablolara göre Microbot Medical Inc'in net pérdida $-13'dir.
Microbot Medical Inc'in herhangi bir yükümlülüğü var mı?
sí, Microbot Medical Inc'in yükümlülüğü 3'dir.
Microbot Medical Inc'in tedavüldeki hisse sayısı kaçtır?
Microbot Medical Inc'in toplam tedavüldeki hisse sayısı 67.15'dir.